AHA supports $100M telehealth pilot

The American Hospital Association voiced its support for a $100 million telehealth pilot by the Federal Communications Commission (FCC) in written comments.

The pilot, which was announced by the FCC in July, takes aim at improving healthcare services for low-income Americans, those living in rural areas and veterans. The project, dubbed the Connected Care Pilot, could give healthcare providers up to $5 million in funding to connect low-income patients.

AHA represents nearly 5,000 hospitals, healthcare systems, networks and other providers and has 43,000 individual members. While the association broadly supports the pilot, it urged the FCC to carefully consider some of the obligations of healthcare providers in the funding equation to encourage more participation. AHA also voiced support for a simple application process for providers interested in participating, keeping metrics realistic and relevant, and opening the project up to a wide breadth of healthcare providers.

“Given the complexity of human health, it can be very difficult to link a single telehealth intervention to outcomes, such as mortality or even hospitalizations,” the comments read. “Thus, the Commission should consider permitting more specific measurement methodologies that are directly linked to the interventions that are funded.”

In addition, AHA supported keeping the definition of eligible patients flexible. The comments may help shape the scope of the pilot as it moves forward.

“The Connected Care Pilot Program is an important next step towards delivering affordable telehealth services to those Americans who need it the most,” AHA concluded.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.